Cargando…

Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects

Several systemic factors indicate that worldwide herd immunity against COVID-19 will probably not be achieved in 2021. On the one hand, vaccination programs are limited by availability of doses and on the other hand, the number of people already infected is still too low to have a disease preventing...

Descripción completa

Detalles Bibliográficos
Autores principales: Bicher, Martin, Rippinger, Claire, Schneckenreither, Günter, Weibrecht, Nadine, Urach, Christoph, Zechmeister, Melanie, Brunmeir, Dominik, Huf, Wolfgang, Popper, Niki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861103/
https://www.ncbi.nlm.nih.gov/pubmed/35190590
http://dx.doi.org/10.1038/s41598-022-06771-x
_version_ 1784654814790025216
author Bicher, Martin
Rippinger, Claire
Schneckenreither, Günter
Weibrecht, Nadine
Urach, Christoph
Zechmeister, Melanie
Brunmeir, Dominik
Huf, Wolfgang
Popper, Niki
author_facet Bicher, Martin
Rippinger, Claire
Schneckenreither, Günter
Weibrecht, Nadine
Urach, Christoph
Zechmeister, Melanie
Brunmeir, Dominik
Huf, Wolfgang
Popper, Niki
author_sort Bicher, Martin
collection PubMed
description Several systemic factors indicate that worldwide herd immunity against COVID-19 will probably not be achieved in 2021. On the one hand, vaccination programs are limited by availability of doses and on the other hand, the number of people already infected is still too low to have a disease preventing impact and new emerging variants of the virus seem to partially neglect developed antibodies from previous infections. Nevertheless, by February 2021 after one year of observing high numbers of reported COVID-19 cases in most European countries, we might expect that the immunization level should have an impact on the spread of SARS-CoV-2. Here we present an approach for estimating the immunization of the Austrian population and discuss potential consequences on herd immunity effects. To estimate immunization we use a calibrated agent-based simulation model that reproduces the actual COVID-19 pandemic in Austria. From the resulting synthetic individual-based data we can extract the number of immunized persons. We then extrapolate the progression of the epidemic by varying the obtained level of immunization in simulations of an hypothetical uncontrolled epidemic wave indicating potential effects on the effective reproduction number. We compared our theoretical findings with results derived from a classic differential equation SIR-model. As of February 2021, [Formula: see text] of the Austrian population has been affected by a SARS-CoV-2 infection which causes a [Formula: see text] reduction of the effective reproduction number and a [Formula: see text] reduction of the prevalence peak compared to a fully susceptible population. This estimation is now recomputed on a regular basis to publish model based analysis of immunization level in Austria also including the fast growing effects of vaccination programs. This provides substantial information for decision makers to evaluate the necessity of non pharmaceutical intervention measures based on the estimated impact of natural and vaccinated immunization.
format Online
Article
Text
id pubmed-8861103
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88611032022-02-23 Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects Bicher, Martin Rippinger, Claire Schneckenreither, Günter Weibrecht, Nadine Urach, Christoph Zechmeister, Melanie Brunmeir, Dominik Huf, Wolfgang Popper, Niki Sci Rep Article Several systemic factors indicate that worldwide herd immunity against COVID-19 will probably not be achieved in 2021. On the one hand, vaccination programs are limited by availability of doses and on the other hand, the number of people already infected is still too low to have a disease preventing impact and new emerging variants of the virus seem to partially neglect developed antibodies from previous infections. Nevertheless, by February 2021 after one year of observing high numbers of reported COVID-19 cases in most European countries, we might expect that the immunization level should have an impact on the spread of SARS-CoV-2. Here we present an approach for estimating the immunization of the Austrian population and discuss potential consequences on herd immunity effects. To estimate immunization we use a calibrated agent-based simulation model that reproduces the actual COVID-19 pandemic in Austria. From the resulting synthetic individual-based data we can extract the number of immunized persons. We then extrapolate the progression of the epidemic by varying the obtained level of immunization in simulations of an hypothetical uncontrolled epidemic wave indicating potential effects on the effective reproduction number. We compared our theoretical findings with results derived from a classic differential equation SIR-model. As of February 2021, [Formula: see text] of the Austrian population has been affected by a SARS-CoV-2 infection which causes a [Formula: see text] reduction of the effective reproduction number and a [Formula: see text] reduction of the prevalence peak compared to a fully susceptible population. This estimation is now recomputed on a regular basis to publish model based analysis of immunization level in Austria also including the fast growing effects of vaccination programs. This provides substantial information for decision makers to evaluate the necessity of non pharmaceutical intervention measures based on the estimated impact of natural and vaccinated immunization. Nature Publishing Group UK 2022-02-21 /pmc/articles/PMC8861103/ /pubmed/35190590 http://dx.doi.org/10.1038/s41598-022-06771-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bicher, Martin
Rippinger, Claire
Schneckenreither, Günter
Weibrecht, Nadine
Urach, Christoph
Zechmeister, Melanie
Brunmeir, Dominik
Huf, Wolfgang
Popper, Niki
Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
title Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
title_full Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
title_fullStr Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
title_full_unstemmed Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
title_short Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
title_sort model based estimation of the sars-cov-2 immunization level in austria and consequences for herd immunity effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861103/
https://www.ncbi.nlm.nih.gov/pubmed/35190590
http://dx.doi.org/10.1038/s41598-022-06771-x
work_keys_str_mv AT bichermartin modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT rippingerclaire modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT schneckenreithergunter modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT weibrechtnadine modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT urachchristoph modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT zechmeistermelanie modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT brunmeirdominik modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT hufwolfgang modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects
AT popperniki modelbasedestimationofthesarscov2immunizationlevelinaustriaandconsequencesforherdimmunityeffects